Financials

  • Market Capitalization 30.39 M
  • Employee 109
  • Founded 2010
  • CEO N/A
  • Website www.fractyl.com
  • Headquarter Delaware, United States
  • FIGI BBG002Y7NH72
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.27
Price to sales ratio
964.47
Dividends per share
Dividend yield %

Fractyl Health Inc

Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1.

Haberler